Japan M&A: Prescription for growth

The cross-border acquisitions that JapanÆs pharmaceutical companies are announcing could be just what the doctor ordered, even though they come with hefty price tags.
November 16, 2008

Japan's Takeda pays $8.8 billion for Millennium

Takeda's purchase of US oncology firm Millennium represents Japan's largest outbound pharmaceuticals acquisition, but shareholders and analysts are questioning the offer price.
April 13, 2008